CellSource Co Ltd
TSE:4880
CellSource Co Ltd
Operating Income
CellSource Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellSource Co Ltd
TSE:4880
|
Operating Income
¥1.2B
|
CAGR 3-Years
43%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Carna Biosciences Inc
TSE:4572
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-14%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Income
¥5.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Medinet Co Ltd
TSE:2370
|
Operating Income
-¥1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Linical Co Ltd
TSE:2183
|
Operating Income
¥1.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Operating Income
¥1.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is CellSource Co Ltd's Operating Income?
Operating Income
1.2B
JPY
Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Operating Income amounts to 1.2B JPY.
What is CellSource Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
33%
Over the last year, the Operating Income growth was -22%. The average annual Operating Income growth rates for CellSource Co Ltd have been 43% over the past three years , 33% over the past five years .